Biotech

All Articles

Basilea ratings $268M BARDA financing for antifungals, anti-biotics

.Basilea Pharmaceutica's job cultivating brand new antifungals has actually acquired a considerable ...

Capricor sells Europe civil rights to late-stage DMD therapy for $35M

.Possessing actually gathered up the USA civil liberties to Capricor Therapeutics' late-stage Duchen...

FDA junks adcomm for Applied's rare disease drug

.After dismissing the choice date for Applied Therapeutics' metabolic disorder medicine govorestat, ...

Novo inks $600M NanoVation offer to study genetic drugs ex-liver

.Novo Nordisk is proceeding its push in to hereditary medicines, accepting compensate NanoVation Reh...

Innovent links cytokine to intestines cancer feedbacks

.Innovent Biologics has actually produced the scenario that its own checkpoint inhibitor-cytokine fu...

Merck, Daiichi ADC strikes target in stage 3 bronchi cancer cells research

.A stage 3 test of Daiichi Sankyo and also Merck &amp Co.'s HER3-directed antibody-drug conjugate (A...

Rakovina deepens AI focus with collab to choose cancer cells aim ats

.Five months after Rakovina Therapies turned towards expert system, the cancer-focused biotech has p...

Ascendis' dwarfism medication favorites in stage 3, threatens BioMarin

.Ascendis Pharma has actually become a possible hazard to BioMarin's Voxzogo, stating phase 3 develo...

Despite ph. 3 miss out on, Alkeus sees path ahead for eye health condition property

.Though Alkeus Pharmaceuticals' dental eye health condition possession neglected to substantially le...

Kairos goes social along with $6M IPO to fund trials of cancer medication

.Along with a trio of biotechs reaching the Nasdaq on Friday, it was actually effortless to miss out...